Search

everythinglearnresearchcommunity

for

Search:↓

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

The intestinal lymphatic system is active and promising for targeted drug delivery and therapies.

Baricitinib is effective and safe for treating alopecia areata in Korea.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

COVID-19 vaccines can cause mild to moderate skin reactions, mostly after the first dose.

Skin bacteria help heal wounds and restore healthy skin.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Hydra can help understand human hair follicle microbiomes and develop new skin disease therapies.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Cannabinoids may help treat various skin conditions.

Aging skin causes inflammation that affects the whole body.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Mimicking fetal wound environments may enable scarless healing in adults.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

Nitric Oxide has potential in medicine, especially for infections and heart treatments, but its short life and delivery challenges limit its use.

The new hydrogel speeds up wound healing by reducing inflammation and promoting tissue growth.

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

Mutant keratins cause inflammation in Epidermolysis Bullosa Simplex, suggesting targeting them could help treat the disorder.

The skin microbiome plays a key role in treating atopic dermatitis.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Chemical leukoderma is temporary, while chemical-induced vitiligo can be persistent and harder to treat.

Finasteride may lower cholesterol and slow heart disease progression.

A holistic approach combining medical, surgical, and psychological therapies is essential for effectively managing diabetes.